Evidence map›Paper›PMID 25400826›Full record

ReviewInternational journal of clinical and experimental pathology2014

¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.

Yaping Luo, Wendi Hu, Huanwen Wu, Huadan Xue, Li Huo, Fang Li, Yupei Zhao, Menghua Dai

Abstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaping LuoDepartments of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Wendi HuDepartments of General Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Huanwen WuDepartments of Pathology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Huadan XueDepartments of Radiology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Li HuoDepartments of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Fang LiDepartments of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Yupei ZhaoDepartments of General Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.
Menghua DaiDepartments of General Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a clinicopathologically distinct variant of fibrosarcoma that is capable of recurrence and metastasis. Awareness of imaging features and histopathologic characteristics will be helpful for differential diagnosis from other common tumors. Here, we report a case of SEF metastasizing to the pancreas as a solitary mass mimicking primary pancreatic cancer, and summarize the reported cases with FDG PET/CT from the literature (n=4). PET/CT showed abnormal FDG accumulation (n=2), mild FDG uptake (n=1), or photopenic (n=1). The FDG PET/CT features are closely related to histopathologic characteristics regarding its differentiation and aggressiveness.

Indexed as

Epithelioid CellsFluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedAdultBiopsyDiagnosis, DifferentialFibrosarcomaHumansImmunohistochemistryMaleMultimodal ImagingPancreatic NeoplasmsPancreaticoduodenectomyPredictive Value of TestsFluorodeoxyglucose F18RadiopharmaceuticalsFDGpancreasPET/CTSclerosing epitheloid fibrosarcoma

Identifiers

PMID25400826
PMCPMC4230054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.